Back to Search Start Over

658MO Pembrolizumab (pembro) vs standard-of-care (SOC) in previously treated recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): 6-year follow-up of KEYNOTE-040

Authors :
D. Soulieres
K.J. Harrington
C. Le Tourneau
J.D. Silva
L.F. Licitra
M-J. Ahn
A. Soria
J-P. Machiels
N. Mach
R. Mehra
B. Burtness
J. Lin
N. Lerman
B. Gumuscu
E.E.W. Cohen
Source :
Annals of Oncology. 33:S843
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Subjects

Subjects :
Oncology
Hematology

Details

ISSN :
09237534
Volume :
33
Database :
OpenAIRE
Journal :
Annals of Oncology
Accession number :
edsair.doi...........c7b240d788d4175c80505e572244926a
Full Text :
https://doi.org/10.1016/j.annonc.2022.07.782
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details